The Food and Drug Administration’s (FDA’s) Drug Safety Surveillance During the COVID-19 Pandemic

INTRODUCTION: On 4 February, 2020, the Secretary of the Department of Health and Human Services declared a public health emergency related to coronavirus disease 2019 (COVID-19), and on 27 March, 2020 declared circumstances existed to justify the authorization of the emergency use of drug and biolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Diak, Ida-Lina, Swank, Kimberley, McCartan, Kate, Beganovic, Maya, Kidd, James, Gada, Neha, Kapoor, Rachna, Wolf, Lisa, Kangas, Laura, Wyeth, Jo, Salvatore, Toni, Fanari, Melina, LeBoeuf, Andrew A., Mishra, Poonam, Blum, Michael D., Dal Pan, Gerald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718450/
https://www.ncbi.nlm.nih.gov/pubmed/36460854
http://dx.doi.org/10.1007/s40264-022-01256-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718450/
https://www.ncbi.nlm.nih.gov/pubmed/36460854
http://dx.doi.org/10.1007/s40264-022-01256-2

Ejemplares similares